183 related articles for article (PubMed ID: 19073876)
21. Chlorophyllin chemoprevention in trout initiated by aflatoxin B(1) bath treatment: An evaluation of reduced bioavailability vs. target organ protective mechanisms.
Breinholt V; Arbogast D; Loveland P; Pereira C; Dashwood R; Hendricks J; Bailey G
Toxicol Appl Pharmacol; 1999 Jul; 158(2):141-51. PubMed ID: 10406929
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of chlorophyllin anticarcinogenesis against aflatoxin B1: complex formation with the carcinogen.
Breinholt V; Schimerlik M; Dashwood R; Bailey G
Chem Res Toxicol; 1995 Jun; 8(4):506-14. PubMed ID: 7548730
[TBL] [Abstract][Full Text] [Related]
23. Chemoprevention with chlorophyllin in individuals exposed to dietary aflatoxin.
Egner PA; Muñoz A; Kensler TW
Mutat Res; 2003; 523-524():209-16. PubMed ID: 12628519
[TBL] [Abstract][Full Text] [Related]
24. Chemopreventive properties of chlorophylls towards aflatoxin B1: a review of the antimutagenicity and anticarcinogenicity data in rainbow trout.
Dashwood R; Negishi T; Hayatsu H; Breinholt V; Hendricks J; Bailey G
Mutat Res; 1998 Mar; 399(2):245-53. PubMed ID: 9672663
[TBL] [Abstract][Full Text] [Related]
25. Dietary chlorophyllin is a potent inhibitor of aflatoxin B1 hepatocarcinogenesis in rainbow trout.
Breinholt V; Hendricks J; Pereira C; Arbogast D; Bailey G
Cancer Res; 1995 Jan; 55(1):57-62. PubMed ID: 7805041
[TBL] [Abstract][Full Text] [Related]
26. Cancer chemoprevention by dietary chlorophylls: a 12,000-animal dose-dose matrix biomarker and tumor study.
McQuistan TJ; Simonich MT; Pratt MM; Pereira CB; Hendricks JD; Dashwood RH; Williams DE; Bailey GS
Food Chem Toxicol; 2012 Feb; 50(2):341-52. PubMed ID: 22079312
[TBL] [Abstract][Full Text] [Related]
27. The rainbow trout liver cancer model: response to environmental chemicals and studies on promotion and chemoprevention.
Williams DE
Comp Biochem Physiol C Toxicol Pharmacol; 2012 Jan; 155(1):121-7. PubMed ID: 21704190
[TBL] [Abstract][Full Text] [Related]
28. Animal models for arsenic carcinogenesis: inorganic arsenic is a transplacental carcinogen in mice.
Waalkes MP; Liu J; Ward JM; Diwan BA
Toxicol Appl Pharmacol; 2004 Aug; 198(3):377-84. PubMed ID: 15276417
[TBL] [Abstract][Full Text] [Related]
29. Dibenzo[def,p]chrysene transplacental carcinogenesis in wild-type, Cyp1b1 knockout, and CYP1B1 humanized mice.
Madeen EP; Löhr CV; You H; Siddens LK; Krueger SK; Dashwood RH; Gonzalez FJ; Baird WM; Ho E; Bramer L; Waters KM; Williams DE
Mol Carcinog; 2017 Jan; 56(1):163-171. PubMed ID: 26990437
[TBL] [Abstract][Full Text] [Related]
30. Transplacental initiation of liver, lung, neurogenic, and connective tissue tumors by N-nitroso compounds in mice.
Anderson LM; Hagiwara A; Kovatch RM; Rehm S; Rice JM
Fundam Appl Toxicol; 1989 Apr; 12(3):604-20. PubMed ID: 2731672
[TBL] [Abstract][Full Text] [Related]
31. Post-initiation effects of chlorophyllin and indole-3-carbinol in rats given 1,2-dimethylhydrazine or 2-amino-3-methyl- imidazo.
Xu M; Orner GA; Bailey GS; Stoner GD; Horio DT; Dashwood RH
Carcinogenesis; 2001 Feb; 22(2):309-14. PubMed ID: 11181453
[TBL] [Abstract][Full Text] [Related]
32. Effect of chemopreventive agents on DNA adduction induced by the potent mammary carcinogen dibenzo[a,l]pyrene in the human breast cells MCF-7.
Smith WA; Freeman JW; Gupta RC
Mutat Res; 2001 Sep; 480-481():97-108. PubMed ID: 11506803
[TBL] [Abstract][Full Text] [Related]
33. Fetal mouse susceptibility to transplacental carcinogenesis: differential influence of Ah receptor phenotype on effects of 3-methylcholanthrene, 12-dimethylbenz[a]anthracene, and benzo[a]pyrene.
Anderson LM; Ruskie S; Carter J; Pittinger S; Kovatch RM; Riggs CW
Pharmacogenetics; 1995 Dec; 5(6):364-72. PubMed ID: 8747408
[TBL] [Abstract][Full Text] [Related]
34. Induction of tumors of the liver, lung, ovary and adrenal in adult mice after brief maternal gestational exposure to inorganic arsenic: promotional effects of postnatal phorbol ester exposure on hepatic and pulmonary, but not dermal cancers.
Waalkes MP; Ward JM; Diwan BA
Carcinogenesis; 2004 Jan; 25(1):133-41. PubMed ID: 14514661
[TBL] [Abstract][Full Text] [Related]
35. Demonstration of organotropic effects of chemopreventive agents in multiorgan carcinogenesis models.
Tsuda H; Iwahori Y; Asamoto M; Baba-Toriyama H; Hori T; Kim DJ; Uehara N; Iigo M; Takasuka N; Murakoshi M; Nishino H; Kakizoe T; Araki E; Yazawa K
IARC Sci Publ; 1996; (139):143-50. PubMed ID: 8923026
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of chlorophyllin anticarcinogenesis: dose-responsive inhibition of aflatoxin uptake and biodistribution following oral co-administration in rainbow trout.
Hayashi T; Schimerlik M; Bailey G
Toxicol Appl Pharmacol; 1999 Jul; 158(2):132-40. PubMed ID: 10406928
[TBL] [Abstract][Full Text] [Related]
37. Toxicology and carcinogenesis studies of transplacental AZT (Cas No. 30516-87-1) in Swiss (CD-1®) mice (in utero studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jun; (522):1-184. PubMed ID: 17160102
[TBL] [Abstract][Full Text] [Related]
38. 32P-postlabeling assay in mice of transplacental DNA damage induced by the environmental carcinogens safrole, 4-aminobiphenyl, and benzo(a)pyrene.
Lu LJ; Disher RM; Reddy MV; Randerath K
Cancer Res; 1986 Jun; 46(6):3046-54. PubMed ID: 3698023
[TBL] [Abstract][Full Text] [Related]
39. Transplacental carcinogenicity of inorganic arsenic in the drinking water: induction of hepatic, ovarian, pulmonary, and adrenal tumors in mice.
Waalkes MP; Ward JM; Liu J; Diwan BA
Toxicol Appl Pharmacol; 2003 Jan; 186(1):7-17. PubMed ID: 12583988
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ)-DNA binding in rats given chlorophyllin: dose-response and time-course studies in the liver and colon.
Guo D; Dashwood R
Carcinogenesis; 1994 Apr; 15(4):763-6. PubMed ID: 8149493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
